Library — CHDR

Search

Filter

Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids.

Strougo A, Zuurman L, Roy C, Pinquier JL, van Gerven JM, Cohen AF, Schoemaker RC

Journal of psychopharmacology (Oxford, England), 2008 Aug; 22(7):717-26

View publication
Effect of intrapulmonary tetrahydrocannabinol administration in humans.

Zuurman L, Roy C, Schoemaker RC, Hazekamp A, den Hartigh J, Bender JC, Verpoorte R, Pinquier JL, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2008 Aug; 22(7):707-16

View publication
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.

de Haas SL, de Visser SJ, van der Post JP, Schoemaker RC, van Dyck K, Murphy MG, de Smet M, Vessey LK, Ramakrishnan R, Xue L, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2007 Dec; 22(1):24-32

View publication
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.

de Haas SL, de Visser SJ, van der Post JP, de Smet M, Schoemaker RC, Rijnbeek B, Cohen AF, Vega JM, Agrawal NG, Goel TV, Simpson RC, Pearson LK, Li S, Hesney M, Murphy MG, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2007 May; 21(4):374-83

View publication
Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study.

Trenité DG, French JA, Hirsch E, Macher JP, Meyer BU, Grosse PA, Abou-Khalil BW, Rosenfeld WE, van Gerven J, Novak GP, Parmeggiani L, Schmidt B, Gibson D, Guerrini R

Epilepsy research, 2007 Apr; 74(2-3):193-200

View publication
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693.

van der Post JP, de Visser SJ, de Kam ML, Woelfler M, Hilt DC, Vornov J, Burak ES, Bortey E, Slusher BS, Limsakun T, Cohen AF, van Gerven JM

British journal of clinical pharmacology, 2005 Jul; 60(2):128-36

View publication
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.

Dumont GJ, de Visser SJ, Cohen AF, van Gerven JM,

British journal of clinical pharmacology, 2005 Apr; 59(5):495-510

View publication
The psychomotor effects of carbamazepine in epileptic patients and healthy volunteers.

Pieters MS, van Steveninck AF, Schoemaker RC, Kroon JM, van Gerven JM, Cohen AF

Journal of psychopharmacology (Oxford, England), 2003 Aug; 17(3):269-72

View publication
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers.

Rijnbeek B, de Visser SJ, Franson KL, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2003 Jun; 17(2):196-203

View publication

«
1
2
3
4
5
6
7
8
9
10
11
»